Diabetic phenotypes and late-life dementia risk: A mechanism-specific mendelian randomization study

Alzheimer Disease and Associated Disorders

Volumn 30, Issue 1, 2016, Pages 15-20

  Walter, Stefan ^a,c   Marden, Jessica R ^c   Kubzansky, Laura D ^c   Mayeda, Elizabeth R ^a   Crane, Paul K ^d   Chang, Shun Chiao ^c   Cornelis, Marilyn ^c   Rehkopf, David H ^b   Mukherjee, Shubhabrata ^d   Glymour, M Maria ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Dementia; Insulin sensitivity; Mendelian Randomization study; Type 2 diabetes mellitus

Indexed keywords

INSULIN;

ARTICLE; CONTROLLED STUDY; DEMENTIA; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INSULIN SENSITIVITY; LATE LIFE DEMENTIA; MENDELIAN RANDOMIZATION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET CELL FUNCTION; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ALZHEIMER DISEASE; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; PROCEDURES; RISK FACTOR;

ALZHEIMER DISEASE; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; MENDELIAN RANDOMIZATION ANALYSIS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84960812445     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000128     Document Type: Article

References (40)

1. Strachan MW, Reynolds RM, Marioni RE, et al. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol. 2011;7:108-114.
2. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369:540-548.
3. Arterburn DE, Crane PK, Sullivan SD. The coming epidemic of obesity in elderly Americans. J Am Geriatr Soc. 2004;52: 1907-1912.
4. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7:137-152.
5. Lam DW, LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes. 2012;19:93-96.
6. Narayan KM, Boyle JP, Thompson TJ, et al. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30: 1562-1566.
7. Beydoun MA, Beydoun HA, Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev. 2008;9:204-218.
8. Nandi A, Glymour MM, Kawachi I, et al. Using marginal structural models to estimate the direct effect of adverse childhood social conditions on onset of heart disease, diabetes, and stroke. Epidemiology. 2012;23:223-232.
9. Danese A, Moffitt TE, Harrington H, et al. Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med. 2009;163:1135-1143.
10. Stewart R, Masaki K, Xue QL, et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2005;62:55-60.
11. Wang L, Larson EB, Bowen JD, et al. Performance-based physical function and future dementia in older people. Arch Intern Med. 2006;166:1115-1120.
12. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981-990.
13. Mahajan A, Go MJ, Zhang W, et al. Genome-wide transancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014; 46:234-244.
14. Østergaard SD, Mukherjee S, Sharp SJ, et al. Associations between potentially modifiable risk factors and Alzheimer disease: a Mendelian randomization study. PLoS Med. 2015; 12:e1001841.
15. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565-1572.
16. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Metaanalysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45:1452-1458.
17. Juster F, Suzman R. An overview of the health and retirement study. J Hum Resour. 1995;30(suppl):S7-S56.
18. Heeringa SG, Connor JH. Technical Description of the Health and Retirement Survey Sample Design. Ann Arbor, MI: University of Michigan; 1995.
19. Ofstedal MB, Fisher GG, Herzog AR. Documentation of Cognitive Functioning Measures in the Health and Retirement Study. Ann Arbor, MI: University of Michigan; 2005.
20. Wu Q, Tchetgen Tchetgen EJ, Osypuk TL, et al. Combining direct and proxy assessments to reduce attrition bias in a longitudinal study. Alzheimer Dis Assoc Disord. 2013;27: 207-212.
21. Shen L, Walter S, Melles RB, et al. Diabetes pathology and risk of primary open-angle glaucoma: evaluating causal mechanisms using genetic information. Am J Epidemiol. (In press).
22. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658-665.
23. Crimmins E, Guyer H, Langa K, et al. Documentation of Biomarkers in the health and Retirement Study (HRS Documentation Report). Ann Arbor, MI: University of Michigan, Survey Research Center; 2008. Available at: http://hrsonline. isr.umich.edu.
24. Glymour MM, Tchetgen EJ, Robins JM. Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions. Am J Epidemiol. 2012;175: 332-339.
25. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression. Int J Epidemiol. 2015;44: 512-525.
26. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2014.
27. Luchsinger JA. Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention? J Alzheimers Dis. 2010;20:723-736.
28. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80:844-866.
29. Nunomura A, Perry G, Aliev G, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60:759-767.
30. Rogers J, Mastroeni D, Leonard B, et al. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int Rev Neurobiol. 2007;82: 235-246.
31. Halliday G, Robinson SR, Shepherd C, et al. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Clin Exp Pharmacol Physiol. 2000;27:1-8.
32. Srikanth V, Maczurek A, Phan T, et al. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol Aging. 2011;32:763-777.
33. Luchsinger JA, Palmas W, Teresi JA, et al. Improved diabetes control in the elderly delays global cognitive decline. J Nutr Health Aging. 2011;15:445-449.
34. Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969-977.
35. Mukherjee S, Walter S, Kauwe JS, et al. Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses. Alzheimers Dement. 2015. (In press).
36. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
37. Bergman RN, Finegood DT, Kahn SE. The evolution of betacell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest. 2002;32(suppl 3):35-45.
38. Cheng G, Huang C, Deng H, et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42:484-491.
39. Biessels GJ, Strachan MW, Visseren FL, et al. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2:246-255.
40. MacArthur DG, Manolio TA, Dimmock DP, et al. Guidelines for investigating causality of sequence variants in human disease. Nature. 2014;508:469-476.